Opening the iTunes Store.If iTunes doesn't open, click the iTunes application icon in your Dock or on your Windows desktop.Progress Indicator
Opening the iBooks Store.If iBooks doesn't open, click the iBooks app in your Dock.Progress Indicator

iTunes is the world's easiest way to organize and add to your digital media collection.

We are unable to find iTunes on your computer. To download and subscribe to Sepsis:KnowFromDay1 by bioMérieux, get iTunes now.

Already have iTunes? Click I Have iTunes to open it now.

I Have iTunes Free Download
iTunes for Mac + PC


By bioMérieux

To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.


Sepsis is a critical, life-threatening condition, which results in more than 200,000 deaths in the U.S. every year. The SepsisKnowFromDay1 podcast series, sponsored by bioMérieux, features panel discussions and presentations by experts in the fields of diagnostics, critical care, emergency medicine and infectious diseases in the diagnosis and management of this complex condition. Over the past decade, numerous scientific and clinical studies have investigated the use of a novel biomarker known as procalcitonin, or PCT, as a diagnostic test to aid in the assessment of sepsis. This series provides a forum for scientific exchange and the sharing of experiences to help in the understanding and management of patients suspected of having sepsis. Please subscribe to the podcast to receive the latest episodes as they are released. Additionally, we encourage you to share this podcast series with your friends and colleagues. Additional podcasts and webinars from bioMérieux on how industry experts utilize procalcitonin and other clinical information to better assess and manage patients can also be found at

Listeners also subscribed to

iCritical Care: LearnICU
Critical Care Practitioner
View in iTunes
  • Free
  • Category: Medicine
  • Language: English

Customer Ratings

We have not received enough ratings to display an average for this podcast.